Inactive Instrument

News Intersect ENT, Inc.

Equities

XENT

US46071F1030

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Intersect ENT, Inc.(NasdaqGM:XENT) dropped from S&P Healthcare Equipment Select Industry Index	22-05-17	CI
Intersect ENT, Inc.(NasdaqGM:XENT) dropped from S&P TMI Index	22-05-17	CI
Intersect ENT, Inc.(NasdaqGM:XENT) dropped from S&P Global BMI Index	22-05-17	CI
INTERSECT ENT, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	22-05-13	AQ
Medtronic Completes Purchase Of US Medical Device Group Intersect ENT	22-05-13	MT
Medtronic Completes Purchase of Intersect ENT	22-05-13	MT
Intersect ENT, Inc.(NasdaqGM:XENT) dropped from NASDAQ Composite Index	22-05-13	CI
Hemostasis, LLC acquired Fiagon AG Medical Technologies from Intersect ENT, Inc.	22-05-12	CI
Medtronic plc completed the acquisition of Intersect ENT, Inc..	22-05-12	CI
INTERSECT ENT, INC. : Other Events (form 8-K)	22-05-09	AQ
INTERSECT ENT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-05-04	AQ
Intersect ENT, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-04	CI
INTERSECT ENT, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-04-18	AQ
Intersect ENT, Inc. Enters into Amendment No.1 to Facility Agreement	22-04-18	CI
INTERSECT ENT, INC. : Other Events (form 8-K)	22-03-23	AQ
INTERSECT ENT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	22-03-08	AQ
Intersect ENT, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-08	CI
Intersect ENT Reports Positive Data From Real-World Evidence Study of Propel Sinus Implants	22-01-25	MT
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization	22-01-25	BU
Intersect ENT®, Inc. Announces Positive Results of Observational	22-01-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Intersect ENT, Inc.

Equities

XENT

US46071F1030

Summary

Filters